ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag venture capital disease medicine

Venture Capital, with a Twist
Ted Agres(tagres@the-scientist.com) | Jul 17, 2005 | 5 min read
Jamie Heywood, chief executive of the Amyotrophic Lateral Sclerosis Therapy Development Foundation (ALSTDF), founded the nonprofit biotech company in 1999 after his brother was diagnosed with ALS.
bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
Adventure with Ventures
Ted Agres(tagres@the-scientist.com) | Feb 27, 2005 | 9 min read
Bruce Weintraub is a cofounder and chief executive of Trophogen, a biotech startup in Rockville, Md., that develops protein therapeutics.
THE STATE OF REGENERATIVE MEDICINE
Ed Field | Apr 1, 2007 | 4 min read
By Ed FieldTHE STATE OF REGENERATIVE MEDICINENorth Carolina has the resources, but needs a plan to advance. Ed Field is president and CEO of Aldagen, a clinical stage, regenerative medicine company in Durham, NC JASON VARNEY | VARNEYPHOTO.COM One of the most promising forms of emerging therapy is the use of a person's own or a donor's cells to treat a variety of diseases. This approach, often called cell therapy and more recently regenerative medici
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
New medicine means research rethink
Erik Vance | Jun 2, 2009 | 2 min read
It's time to re-evaluate how we define cancers, researchers say
The New Medicine Man
Christopher Smith | Feb 20, 2000 | 9 min read
Courtesy of Zymark Combinatorial Chemistry Products and Services Finding cures for cancer, AIDS, and the plethora of other ailments that plague humans conjures up images from the 1992 movie Medicine Man. In it, Sean Connery as Dr. Robert Campbell treks through the tropical Amazon forests searching for an enigmatic plant that seems to produce a cancer-curing compound. Although scientists may never approach Mother Nature's ability to create novel compounds, new combinatorial chemistry techniques
The Future Looks Bright for Genetic Medicine
Ronald Crystal | Nov 21, 2004 | 5 min read
Today, gene therapy, genomics, and stem cell therapy are considered to be discrete fields of research.
The MSC: Regeneration Orchestrator
The Scientist Staff | Nov 16, 2020 | 7 min read
Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system and regenerate tissue.
Illustration of DNA
Can “Gene Writing” Deliver What Gene Editing Can’t?
Dan Robitzski | Dec 12, 2022 | 10+ min read
A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?

Run a Search

ADVERTISEMENT